Pfizer briefs NJ public on Superfund site cleanup

Pfizer ($PFE) is all for spreading the word about its cleanup of a contaminated New Jersey site inherited through its acquisition of Wyeth. The drug giant is conducting a PR campaign to inform the public about environmental problems at the American Cyanamid Superfund site and to describe the feasibility studies it ran to prepare a cleanup plan.

The Somerset Messenger-Gazette reports Pfizer produced a 22-minute video that helps translate the project for nonprofessionals. Company representatives were slated to show the video and answer questions about the feasibility studies during two public meetings.

The 435-acre chemical manufacturing site operated from 1915 to 1999, the report said. It made the Environmental Protection Agency's Superfund site list in 1983.

Neither Pfizer nor Wyeth had any role in the contamination, according to the report. Pfizer worked with federal and state officials to develop 8 candidate remediation plans. The EPA is expected later this month to name which of the 8 will be implemented.

- here's the story

Suggested Articles

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S. 

After months of delay for ultra-pricey gene therapy Zynteglo, Bluebird Bio is hoping to dose its first German patients in the first half of the year.

North Carolina is providing some financial assistance for the construction of Audentes gene therapy facility in Sanford, North Carolina. (Astellas)